DIH Holding US, Inc., trading under the ticker DHAI, is a SPAC-related entity operating in the medical technology and rehabilitation robotics sector. The company filed a DEFA14A — definitive additional proxy materials — with the SEC on September 12, 2025, under accession number 0001493152-25-013270, indicating an active shareholder solicitation process, typically associated with a pending business combination vote. DIH Holding focuses on the development and commercialization of rehabilitation and assistive robotics solutions, positioning the vehicle within the high-growth digital health and medtech landscape. For the full sponsor profile, IPO details, deal terms, and live filing timeline on DHAI, sign up for complete data access at SpacDesk.